GSK to go public on clinical trials

British pharmaceuticals giant GlaxoSmithKline today agreed to make public information about all its clinical drug trials following accusations that it misled doctors about the safety of an anti-depressant for children.

The company will become the first major drug manufacturer to disclose such information as the result of a promise made as part of the settlement of a lawsuit filed by New York Attorney General Eliot Spitzer.